Dermtech Stock Investor Sentiment

DMTK Stock  USD 0.59  0.02  3.28%   
About 69% of DermTech's investor base is looking to short. The analysis of the overall investor sentiment regarding DermTech suggests that many traders are alarmed. DermTech's investor sentiment overview provides quick insight into current market opportunities from investing in DermTech. The current market sentiment, together with DermTech's historical and current headlines, can help investors time the market. In addition, many technical investors use DermTech stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
DermTech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of DermTech daily returns and investor perception about the current price of DermTech as well as its diversification or hedging effects on your existing portfolios.
  

DermTech Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards DermTech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at seekingalpha.com         
DermTech exploring strategic alternatives, cutting 56 percent of staff
seekingalpha News
2 days ago at news.google.com         
DermTech receives delisting warning from Nasdaq - LabPulse
Google News at Macroaxis
3 days ago at news.google.com         
DermTech, Inc. Not Doing Enough For Some Investors As Its Shares Slump 37 percent - Yahoo Movies UK
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
over two weeks ago at businesswire.com         
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over two weeks ago at businesswire.com         
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over three weeks ago at news.google.com         
Critical Comparison SeqLL and DermTech - Defense World
Google News at Macroaxis
over three weeks ago at www.macroaxis.com         
Acquisition by Todd Wood of 85114 shares of DermTech subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
DermTech, Inc. Short Interest Update - Defense World
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 445 shares by Sun Kevin M of DermTech at 0.7 subject to Rule 16b-3
Macroaxis News
over a month ago at businesswire.com         
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology Annual Meeting and ...
businesswire News
over a month ago at finance.yahoo.com         
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology Annual Meeting and ...
Yahoo News
over a month ago at thelincolnianonline.com         
Stephens Cuts DermTech Price Target to 1.50
news
over a month ago at businesswire.com         
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology Annual Meeting and ...
businesswire News
over a month ago at www.macroaxis.com         
Disposition of 2531 shares by Sun Kevin M of DermTech at 0.88 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about DermTech that are available to investors today. That information is available publicly through DermTech media outlets and privately through word of mouth or via DermTech internal channels. However, regardless of the origin, that massive amount of DermTech data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of DermTech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of DermTech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to DermTech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive DermTech alpha.

DermTech Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
White Pine Capital LLC Sells 57,907 Shares of DermTech, Inc.
02/14/2024
2
DermTech Q4 2023 Earnings Preview
02/28/2024
3
DermTech Reports Fourth-Quarter 2023 Financial Results
02/29/2024
4
Disposition of 2531 shares by Sun Kevin M of DermTech at 0.88 subject to Rule 16b-3
03/05/2024
5
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology Annual Meeting and New Research Published in the Journal of Investigative Derma...
03/08/2024
6
Acquisition by Todd Wood of 85114 shares of DermTech subject to Rule 16b-3
03/25/2024
7
Critical Comparison SeqLL and DermTech - Defense World
03/26/2024
8
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635
04/01/2024
When determining whether DermTech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if DermTech Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Dermtech Stock. Highlighted below are key reports to facilitate an investment decision about Dermtech Stock:
Check out DermTech Hype Analysis, DermTech Correlation and DermTech Performance.
For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for DermTech Stock analysis

When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.09)
Revenue Per Share
0.469
Quarterly Revenue Growth
0.311
Return On Assets
(0.38)
Return On Equity
(1.06)
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.